Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-18-031836

Options or other derivatives

  • Director acquired 11,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
JUNIUS DANIEL M Director 2018-05-18 Grant or award · Stock Option (right to buy) +11,000 11,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…